Projects per year
Fingerprint
Dive into the research topics where Christopher Coss is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 6 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Active
-
Cachexia-mediated FcRn Modulation and Its Impact on Anti-PD1 Therapy in Lung Cancer
Phelps, M. M. A. (PI), Coss, C. (CoPI), Owen, D. (CoPI) & Mace, T. (CoPI)
08/8/22 → 07/31/25
Project: Research
-
The elucidation of species-specific receptor pharmacology: A case study using subtype-selective para- and meta-carborane estrogen receptor agonists
Adeluola, A. A., Radomska, H. S., Wilson, T. A., Kulp, S. K., Kabat, A., Helms, T. H., Mayo, A. K., Montgomery, E. J., Thomas, J., Marcho, L. M., Costa, T., Fukuda, M., Kang, D. D., Vibhute, S., Wang, D., Bennett, C. E. & Coss, C. C., Jan 2025, In: Journal of Pharmacology and Experimental Therapeutics. 392, 1, 100001.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Antibody drug clearance: an underexplored marker of outcomes with checkpoint inhibitors
Guo, Y., Remaily, B. C., Thomas, J., Kim, K., Kulp, S. K., Mace, T. A., Ganesan, L. P., Owen, D. H., Coss, C. C. & Phelps, M. A., Mar 1 2024, In: Clinical Cancer Research. 30, 5, p. 942-958 17 p.Research output: Contribution to journal › Review article › peer-review
1 Scopus citations -
Decoupling FcRn and tumor contributions to elevated immune checkpoint inhibitor clearance in cancer cachexia
Vu, T. T., Kim, K., Manna, M., Thomas, J., Remaily, B. C., Montgomery, E. J., Costa, T., Granchie, L., Xie, Z., Guo, Y., Chen, M., Castillo, A. M. M., Kulp, S. K., Mo, X., Nimmagadda, S., Gregorevic, P., Owen, D. H., Ganesan, L. P., Mace, T. A. & Coss, C. C. & 1 others, , Jan 2024, In: Pharmacological Research. 199, 107048.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Function-Oriented Synthesis of Pentacyclic Triterpenoids and Discovery of an ent-Estrane as a Natural Product-Inspired Androgen Receptor Antagonist
Stempel, Z. D., Radomska, H. S., Coss, C. C. & Micalizio, G. C., Apr 19 2024, In: Organic Letters. 26, 15, p. 3054-3059 6 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Genome-Wide CRISPR Screen Identifies Phospholipid Scramblase 3 as the Biological Target of Mitoprotective Drug SS-31
Silvaroli, J. A., Bisunke, B., Kim, J. Y., Stayton, A., Jayne, L. A., Martinez, S. A., Nguyen, C., Patel, P. S., Vanichapol, T., Verma, V., Akhter, J., Bolisetty, S., Madhavan, S. M., Kuscu, C., Coss, C. C., Zepeda-Orozco, D., Parikh, S. V., Satoskar, A. A., Davidson, A. J. & Eason, J. D. & 3 others, , Jun 1 2024, In: Journal of the American Society of Nephrology. 35, 6, p. 681-695 15 p.Research output: Contribution to journal › Article › peer-review
4 Scopus citations